Efficacy and safety of 12-hour versus 24-hour magnesium sulfate in management of patients with pre-eclampsia and eclampsia: a systematic review and meta-analysis
Abstract Introduction Magnesium sulfate is the most utilized anticonvulsant for treating patients with eclampsia and pre-eclampsia. The purpose of this study is to determine whether the 12-h regimen of magnesium sulfate outweighs the 24-h regimen in both efficacy and safety in the management of pati...
Saved in:
Main Authors: | Rahma Sameh Shaheen (Author), Rahma Abdelaziz Ismail (Author), Esraa Y. Salama (Author), Sally Median Korini (Author), Ahmed Saad Elsaeidy (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be
by: Pisake Lumbiganon, et al. -
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
by: Smith Jeffrey Michael, et al.
Published: (2013) -
Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial
by: Paulino Vigil-De Gracia, et al.
Published: (2017) -
Serum Magnesium Level in Severe Preeclampsia and Eclampsia Undergoing Magnesium Sulfate Therapy at Chonburi Hospital
by: Kittiporn Preedatham, et al.
Published: (2010) -
Correlation of 2 hour, 4 hour, 8 hour and 12 hour urine protein with 24 hour urinary protein in preeclampsia.
by: Savita Rani Singhal, et al.
Published: (2014)